← Back to contracts

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

US · MD National Institutes of Health (NIH) grant open #PAR-25-167
Response due Jan 07, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is offering a federal grant program (PAR-25-167) to fund cancer prevention and control clinical trials through the R01 mechanism. The opportunity is posted on Grants.gov and requires clinical trial activity as a condition of the award. The program opened in November 2024 and accepts applications through January 2027, indicating a multi-cycle funding opportunity. No further scope detail is provided in the synopsis text.

What they want

Technical requirements
  • Clinical trial must be required and conducted as part of the research (R01 Clinical Trial Required designation)

How they evaluate

Submission: Grants.gov federal portal submission

Risks & flags

  • Minimal scope detail provided in synopsis — full funding opportunity announcement (FOA) should be reviewed for eligibility restrictions, specific focus areas, or other limiting criteria that may narrow the applicant pool

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Cancer Prevention and Control Clinical Tri…
Due Jan 07
Onboard ↗